Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
Arbutus Biopharma announced a modified 'Dutch Auction' tender offer to repurchase up to $230 million of its common shares at a price range of $5.00 to $5.75 per share. CEO Lindsay Androski stated the repurchase will be funded by cash on hand, specifically utilizing proceeds from the March 2026 settlement with Moderna and the July 2026 payment.
Key figures
- Deal Value Usd
- 230000000
- Offering Price
- $5.00 - $5.75
- Buyback type
- modified Dutch Auction tender offer
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.